# OnCo record paper-ahmed-promis-multiparametric-mri-lancet-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ahmed-promis-multiparametric-mri-lancet-2017" ;
  schema:name "PROMIS: diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer"@en ;
  schema:alternateName "PROMIS"@en, "Ahmed 2017"@en, "PROMIS multiparametric MRI triage"@en ;
  schema:description "Every man with a raised PSA used to get a needle biopsy through the rectum, which misses half the serious cancers and can cause sepsis. This trial gave 576 men a scan, a standard biopsy and an exhaustive mapping biopsy, and showed the scan could safely spare a quarter of them the needle."@en ;
  schema:url <https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(16)32401-1>, <https://pubmed.ncbi.nlm.nih.gov/28110982/>, <https://clinicaltrials.gov/study/NCT01292291> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(16)32401-1> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Ahmed HU, El-Shater Bosaily A, Brown LC, et al." ;
  onco:related <https://onco.cc/key-papers/paper-precision-mri-targeted-biopsy-nejm-2018/>, <https://onco.cc/key-papers/paper-johnson-mpmri-individual-foci-eur-urol-2019/>, <https://onco.cc/key-papers/paper-goteborg-2-n-engl-j-med-2022/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/imaging/>, <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/prostate-screening-psa-mri/> ;
  onco:institutions <https://onco.cc/institutions/uclh/> ;
  onco:terms <https://onco.cc/terms/psa/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/template-mapping-biopsy/>, <https://onco.cc/terms/pi-rads/>, <https://onco.cc/terms/whole-mount-pathology/> ;
  onco:people <https://onco.cc/people/mark-emberton/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:journals <https://onco.cc/journals/lancet/> .